Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (2): 51-55.doi: 10.6040/j.issn.1673-3770.0.2021.571
• 论著 • Previous Articles
WANG Yubing1, ZHENG Yuebin2, YANG Yirong2, YAN Bincheng2, PENG Shunlin3
CLC Number:
[1] Coggshall K, Tello TL, North JP, et al. Merkel cell carcinoma: an update and review: pathogenesis, diagnosis, and staging[J]. J Am Acad Dermatol, 2018, 78(3):433-442. doi:10.1016/j.jaad.2017.12.001 [2] Agelli M, Clegg LX, Becker JC, et al. The etiology and epidemiology of merkel cell carcinoma[J]. Curr Probl Cancer, 2010, 34(1): 14-37. doi:10.1016/j.currproblcancer.2010.01.001 [3] Tanda ET, d'Amato AL, Rossi G, et al. Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?[J]. Front Oncol, 2021, 11:739006. doi: 10.3389/fonc.2021.739006 [4] Becker JC, Stang A, DeCaprio JA, et al. Merkel cell carcinoma[J]. Nat Rev Dis Primers, 2017, 3: 17077. doi:10.1038/nrdp.2017.77 [5] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Merkel cell carcinoma(Version 2.2022)[EB/OL]. https://www.nccn.org/professionals/physician_gls/pdf/mcc.pdf [6] Wright GP, Holtzman MP. Surgical resection improves Median overall survival with marginal improvement in long-term survival when compared with definitive radiotherapy in Merkel cell carcinoma: a propensity score matched analysis of the National Cancer Database[J]. Am J Surg, 2018, 215(3): 384-387. doi:10.1016/j.amjsurg.2017.10.045 [7] Bhatia S, Storer BE, Iyer JG, et al. Adjuvant radiation therapy and chemotherapy in merkel cell carcinoma: survival analyses of 6908 cases from the national cancer data base[J]. J Natl Cancer Inst, 2016, 108(9): djw042. doi:10.1093/jnci/djw042 [8] Perez MC, Oliver DE, Weitman ES, et al. Management of sentinel lymph node metastasis in merkel cell carcinoma: completion lymphadenectomy, radiation, or both? [J]. Ann Surg Oncol, 2019, 26(2): 379-385. doi:10.1245/s10434-018-6810-1 [9] Lee JS, Durham AB, Bichakjian CK, et al. Completion lymph node dissection or radiation therapy for sentinel node metastasis in merkel cell carcinoma[J]. Ann Surg Oncol, 2019, 26(2): 386-394. doi:10.1245/s10434-018-7072-7 [10] D'Angelo SP, Bhatia S, Brohl AS, et al. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial[J]. Journal for ImmunoTherapy of Cancer, 2020, 8(1):e000674. doi:10.1136/jitc-2020-000674 [11] Nghiem PT, Bhatia S, Lipson EJ, et al. PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma[J]. N Engl J Med, 2016, 374(26): 2542-2552. doi:10.1056/NEJMoa1603702 [12] Topalian SL, Bhatia S, Hollebecque A, et al. Abstract CT074: Non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab(NIVO)in patients with virus-associated tumors(CheckMate 358): efficacy and safety in Merkel cell carcinoma(MCC)[J]. Cancer Res, 2017, 77(13_Supplement): CT074. doi:10.1158/1538-7445.am2017-ct074 [13] Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution[J]. J Clin Oncol, 2005, 23(10): 2300-2309. doi:10.1200/jco.2005.02.329 [14] Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management[J]. Cancer, 2007, 110(1): 1-12. doi:10.1002/cncr.22765 [15] Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2018, 16(6): 742-774. doi:10.6004/jnccn.2018.0055 [16] Lebbe C, Becker JC, Grob JJ, et al. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline[J]. Eur J Cancer, 2015, 51(16): 2396-2403. doi:10.1016/j.ejca.2015.06.131 [17] Hawryluk EB, O'Regan KN, Sheehy N, et al. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center[J]. J Am Aca Dermatol, 2013, 68(4):592-599. doi:10.1016/j.jaad.2012.08.042 [18] Nghiem P, Bhatia S, Lipson EJ, et al. Durable tumor regression and overall survival in patients with advanced merkel cell carcinoma receiving pembrolizumab as first-line therapy[J]. J Clin Oncol, 2019, 37(9): 693-702. doi:10.1200/JCO.18.01896 [19] 刘绍严, 鄢丹桂. 头颈肿瘤术后缺损修复的现状与展望[J]. 中国耳鼻咽喉颅底外科杂志, 2020, 26(3): 231-234. doi:10.11798/j.issn.1007-1520.202003001 LIU Shaoyan, YAN Dangui. Current situation and prospect of defect repair after head and neck tumor resection[J]. Chinese Journal of Otorhinolaryngology-Skull Base Surgery, 2020, 26(3): 231-234. doi:10.11798/j.issn.1007-1520.202003001 [20] 张礼俊,胥然,罗继芳,等.头颈肿瘤游离皮瓣修复术后皮瓣坏死及皮瓣相关并发症影响因素分析[J].山东大学耳鼻喉眼学报,2022,36(4):86-90. doi:10.6040/j.issn.1673-3770.0.2021.375 ZHANG Lijun, XU Ran, LUO Jifang, et al. Factors affecting flap neurosis and other postoperative flap-related complications after free-flap reconstruction of head and neck tumors[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4):86-90. doi:10.6040/j.issn.1673-3770.0.2021.375 [21] 周晶,陈晓红,马廷耀,等.“点线顺行解剖法”在锁骨上动脉岛状瓣安全制备中的应用[J].中华耳鼻咽喉头颈外科杂志, 2020, 55(9):845-849. doi:10.3760/cma.j.cn115330-20200720-00606 ZHOU Jing, CHEN Xiaohong, MA Tingyao, et al. “Point line anterograde dissection” for the safe preparation of supraclavicular flap[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2020, 55(9):845-849. doi:10.3760/cma.j.cn115330-20200720-00606 [22] 陈仕生, 姚小武, 卢子正,等. 锁骨上动脉岛状瓣修复颌面部肿瘤术后缺损的临床研究[J]. 中华口腔医学研究杂志(电子版), 2017, 11(2): 106-110. doi:10.3877/cma.j.issn.1674-1366.2017.02.007 CHEN Shisheng, YAO Xiaowu, LU Zizheng, et al. Clinical study of the reconstruction of the defect of maxillofacial region with the supraclavicular artery island flap[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2017, 11(2): 106-110. doi:10.3877/cma.j.issn.1674-1366.2017.02.007 |
[1] | JIANG Chao, ZHOU Xuanchen, HAN Jie, YUE Zhiyong. Prevalence and prognostic nomogram for IVc stage hypopharyngeal carcinoma patients: a SEER population-based analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 49-54. |
[2] | XIA Caifeng, XIE Ruiling, ZHEN Zhen, WEN Feng, WANG Quangui. Diagnosis and treatment of renal clear cell carcinoma that has metastasized to the nasal cavity and paranasal sinuses: a case report and systematic review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(5): 36-45. |
[3] | FENG Chen, JIN Xiaoxue, HAN Yingying, ZOU Juanjuan, LI Yanzhong, WANG Yan. Primary localized tonsil amyloidosis: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 99-103. |
[4] | LÜ Dan, LI Mingxia, MA Lanzhi, ZHANG Xinyuan, XIAO Hao, CHEN Fei, LIU Jun, LI Zhen. Neurofibromatosis of the head and neck involving the mediastinum: two cases report [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 82-86. |
[5] | DU Ran, WANG Jialin, WANG Yanling. Different clinical manifestations of retinitis pigmentosa and related imaging features [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 87-90. |
|